Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.
from News Medical Medical Research News Feed https://ift.tt/3hLFbI6
0 Comments